Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20523249rdf:typepubmed:Citationlld:pubmed
pubmed-article:20523249lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20523249lifeskim:mentionsumls-concept:C0346073lld:lifeskim
pubmed-article:20523249lifeskim:mentionsumls-concept:C1367420lld:lifeskim
pubmed-article:20523249lifeskim:mentionsumls-concept:C0042679lld:lifeskim
pubmed-article:20523249pubmed:issue6lld:pubmed
pubmed-article:20523249pubmed:dateCreated2010-8-6lld:pubmed
pubmed-article:20523249pubmed:abstractTextKaposiform hemangioendothelioma (KHE) and tufted angioma (TA) are rare, locally aggressive vascular tumors. Although currently classified as separate entities, they are becoming increasingly recognized as a spectrum of the same pathology. There is a well-recognized association with Kasabach-Merritt phenomenon KHE and TA are considered neoplasms of intermediate malignancy because of infiltrative growth, local aggressiveness, and variable prognosis. To date, definitive treatment for these vascular tumors has had limited success.lld:pubmed
pubmed-article:20523249pubmed:languageenglld:pubmed
pubmed-article:20523249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20523249pubmed:citationSubsetIMlld:pubmed
pubmed-article:20523249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20523249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20523249pubmed:statusMEDLINElld:pubmed
pubmed-article:20523249pubmed:monthAuglld:pubmed
pubmed-article:20523249pubmed:issn1536-3678lld:pubmed
pubmed-article:20523249pubmed:authorpubmed-author:ArbuckleSusan...lld:pubmed
pubmed-article:20523249pubmed:authorpubmed-author:McCahonEmmaElld:pubmed
pubmed-article:20523249pubmed:authorpubmed-author:FahrtashFarza...lld:pubmed
pubmed-article:20523249pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20523249pubmed:volume32lld:pubmed
pubmed-article:20523249pubmed:ownerNLMlld:pubmed
pubmed-article:20523249pubmed:authorsCompleteYlld:pubmed
pubmed-article:20523249pubmed:pagination506-10lld:pubmed
pubmed-article:20523249pubmed:dateRevised2011-10-6lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:meshHeadingpubmed-meshheading:20523249...lld:pubmed
pubmed-article:20523249pubmed:year2010lld:pubmed
pubmed-article:20523249pubmed:articleTitleSuccessful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine.lld:pubmed
pubmed-article:20523249pubmed:affiliationDepartment of Pediatrics and Child Health, The University of Sydney, Sydney, New South Wales, Australia.lld:pubmed
pubmed-article:20523249pubmed:publicationTypeJournal Articlelld:pubmed